ConductScience.org, home

Trial · NCT07242612

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

NCT07242612, Not applicable, Completed, Khyber Medical University Peshawar

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis. Trials, record NCT07242612. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07242612

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
NCT number
NCT07242612
Status
Completed
Phases
Not applicable
Enrollment
40 participants, actual
Lead sponsor
Khyber Medical University Peshawar
Conditions
Osteoporosis, Osteoporosis, Postmenopausal
Interventions
Alendronate, Ibandronate; Risedronate, Teriparatide
First posted
2025-11-21
Last updated
2026-08-13

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Bone Turnover Markers (BTMs)Baseline, 3 months, and 6 months.
Mean change from baseline in the serum levels of specific bone turnover markers, including the bone formation marker Bone-Specific Alkaline Phosphatase (BsALP) and the bone resorption marker Tartrate-Resistant Acid Phosphatase 5b (TRACP-5b), and the osteocyte marker Sclerostin.
PrimaryChange in Bone Mineral Density (BMD)Baseline and 6 months.Mean change from baseline in Bone Mineral Density (BMD) T-score as measured by Dual-Energy X-ray Absorptiometry (DEXA) scans at the hip, spine, and femoral neck.
SecondaryIncidence of New FracturesThrough study completion, an average of 6 months.The number of participants who experience any new fragility fractures during the study period.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
28455749BACKGROUNDPubMed
29623238BACKGROUNDPubMed
30449552BACKGROUNDPubMed
31419313BACKGROUNDPubMed
31440982BACKGROUNDPubMed
32887359BACKGROUNDPubMed
33382995BACKGROUNDPubMed
37204537BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07242612

GET https://conductscience.org/api/trials/v1/NCT07242612/registered